Virtu Financial’s Blonder Tongue Laboratories Inc BDR Stock Holding History

Virtu Financial’s Portfolio BDR Stock Details BDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-49,857	Closed	-$32K	–	2377
2022 Q1	$32K	Buy	49,857 +24,780	+99%	+$13.3K	﹤0.01%	1230
2021 Q4	$15K	Buy	+25,077	New	+$23.7K	﹤0.01%	1549
2021 Q3	–	Sell	-85,882	Closed	-$113K	–	2254
2021 Q2	$113K	Buy	+85,882	New	+$105K	0.01%	1177
2021 Q1	–	Sell	-15,059	Closed	-$20K	–	2262
2020 Q4	$20K	Sell	15,059 -40,838	-73%	-$48.2K	﹤0.01%	1358
2020 Q3	$46K	Buy	+55,897	New	+$45.7K	0.01%	836
2018 Q1	–	Sell	-36,830	Closed	-$22K	–	2834
2017 Q4	$22K	Buy	36,830 +13,426	+57%	+$6.44K	﹤0.01%	2210
2017 Q3	$11K	Buy	+23,404	New	+$12.2K	﹤0.01%	2407

Virtu Financial's BDR Position: Q2 2022 in Review

Virtu Financial sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 49,857 shares — an estimated $32K sold.

Virtu Financial first reported a position in BDR in Q3 2017 and held it in 7 quarters. The position peaked at $113K in Q2 2021. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.

Virtu Financial reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
Virtu Financial sold 49,857 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $32K.
Virtu Financial first reported a position in Blonder Tongue Laboratories Inc in Q3 2017 and held it in 7 quarters.
Virtu Financial's Blonder Tongue Laboratories Inc position peaked at $113K in Q2 2021.
0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.